These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19107048)

  • 1. [Fluoroquinolones in ophthalmology: indications and current use].
    Chiquet C; Labetoulle M
    J Fr Ophtalmol; 2008 Oct; 31(8):803-8. PubMed ID: 19107048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fluoroquinolones in ophthalmology: mechanisms of action and resistance].
    Labetoulle M; Chiquet C
    J Fr Ophtalmol; 2008 Oct; 31(8):795-801. PubMed ID: 19107047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravitreal injection of antibiotics in endophthalmitis].
    Cornut PL; Chiquet C
    J Fr Ophtalmol; 2008 Oct; 31(8):815-23. PubMed ID: 19107050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones.
    Chawla B; Agarwal P; Tandon R; Titiyal JS; Sharma N; Agarwal T; Navak N; Satpathy G
    Eur J Ophthalmol; 2010; 20(2):300-5. PubMed ID: 19924668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal use of fluoroquinolones in the intensive care unit setting.
    Rotschafer JC; Ullman MA; Sullivan CJ
    Crit Care Clin; 2011 Jan; 27(1):95-106. PubMed ID: 21144988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal piperacillin/tazobactam in the management of multidrug-resistant Pseudomonas aeruginosa endophthalmitis.
    Pathengay A; Mathai A; Shah GY; Ambatipudi S
    J Cataract Refract Surg; 2010 Dec; 36(12):2210-1. PubMed ID: 21111328
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraocular penetration of systemic antibiotics in eyes with penetrating ocular injury.
    Ahmed S; Kuruvilla O; Yee DC; Aggarwal H; Li Y; Edwards P; Qiao X; Gao H
    J Ocul Pharmacol Ther; 2014 Dec; 30(10):823-30. PubMed ID: 25167230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolones: place in ocular therapy.
    Smith A; Pennefather PM; Kaye SB; Hart CA
    Drugs; 2001; 61(6):747-61. PubMed ID: 11398907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis.
    Ferencz JR; Assia EI; Diamantstein L; Rubinstein E
    Arch Ophthalmol; 1999 Aug; 117(8):1023-7. PubMed ID: 10448744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections.
    Bassetti M; Pecori D; Cojutti P; Righi E; Pea F
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1193-1200. PubMed ID: 28988505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment.
    Relhan N; Albini TA; Pathengay A; Kuriyan AE; Miller D; Flynn HW
    Br J Ophthalmol; 2016 Apr; 100(4):446-52. PubMed ID: 26701686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
    Scoper SV
    Adv Ther; 2008 Oct; 25(10):979-94. PubMed ID: 18836691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics in endophthalmitis: microbiological and pharmacokinetic considerations.
    López-Cabezas C; Muner DS; Massa MR; Mensa Pueyo JM
    Curr Clin Pharmacol; 2010 Feb; 5(1):47-54. PubMed ID: 20236082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
    Alexandrakis G; Alfonso EC; Miller D
    Ophthalmology; 2000 Aug; 107(8):1497-502. PubMed ID: 10919897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of 342 cases of endogenous bacterial endophthalmitis.
    Jackson TL; Paraskevopoulos T; Georgalas I
    Surv Ophthalmol; 2014; 59(6):627-35. PubMed ID: 25113611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis.
    Ghelardi E; Tavanti A; Davini P; Celandroni F; Salvetti S; Parisio E; Boldrini E; Senesi S; Campa M
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3396-401. PubMed ID: 15328102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features, Antibiotic Susceptibility Profiles, and Outcomes of Infectious Keratitis Caused by Achromobacter xylosoxidans.
    Spierer O; Monsalve PF; OʼBrien TP; Alfonso EC; Gologorsky D; Miller D
    Cornea; 2016 May; 35(5):626-30. PubMed ID: 26989957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial keratitis.
    Liesegang TJ
    Infect Dis Clin North Am; 1992 Dec; 6(4):815-29. PubMed ID: 1460265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials.
    McDonald EM; Ram FS; Patel DV; McGhee CN
    Br J Ophthalmol; 2014 Nov; 98(11):1470-7. PubMed ID: 24729078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postkeratoplasty endophthalmitis by Alcaligenes faecalis: a case report.
    Khokhar DS; Sethi HS; Kumar H; Sudan R; Sharma N; Nayak N
    Cornea; 2002 Mar; 21(2):232-3. PubMed ID: 11862104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.